| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Whitley Richard James is a Director at GILD, with reported holdings spanning 2 companies. Recent filings cover 3 purchases and 4 sales. Those positions are worth an estimated $4.6M at current prices.
Our model assigns Whitley Richard James a below-average insider score of 25/100, based on 5 past trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -72.5%.
Whitley Richard James's largest disclosed position is in GILD as Director, worth about $4.6M. The recent filings there lean toward selling, a net 39,350 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2022 | DWTX Dogwood Therapeutics, Inc. | Director | Sell | 1,800 | $0.26 | $466.38 | -72.0% | +33.4% | +152.0% | |
| May 18, 2022 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 500 | $4.53 | $2,262.50 | +25.0% | +46.8% | -75.9% | |
| Jan 6, 2022 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 1,800 | $5.72 | $10,296.00 | +900.0% | -20.9% | -95.5% | |
| Dec 23, 2021 | DWTX Dogwood Therapeutics, Inc. | Director | Buy | 200 | $5.73 | $1,145.00 | New | -6.5% | -95.3% | |
| May 3, 2021 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 20,282 | $64.57 | $1,309,655.39 | -39.5% | +5.0% | -4.3% | |
| May 1, 2019 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 9,534 | $65.02 | $619,934.05 | -27.5% | - | - | |
| Apr 1, 2019 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 9,534 | $65.48 | $624,254.86 | -27.5% | - | - |